Understanding proper syringe dosage is equally important
Exercise is safe and beneficial during GLP-1 treatment but start slowly, especially during dose titration Strength training is the most important form of exercise for preserving muscle mass during weight loss Walking, swimming, and cycling are excellent low-impact cardiovascular options PEAK integrates personalized movement plans into every patients treatment protocol One of the most common questions patients ask after starting a GLP-1 medication like Wegovy, Zepbound, or Foundayo is whether it is safe to exercise
Now, patients have access to once-weekly injections and an oral formulation, semaglutide (Rybelsus), for those who prefer to avoid needles. GLP-1s and the ADA Guidelines: A New First-Line Therapy The American Diabetes Associations 2024 Standards of Care are clear: GLP-1 RAs are often first-line agents for patients with type 2 diabetes who also have atherosclerotic cardiovascular disease, chronic kidney disease, or obesity. For patients with a body mass index (BMI) of 30 kg/m or higher or elevated cardiovascular risk, semaglutide or tirzepatide may be considered before initiating metformin, especially when weight loss or cardioprotection is the top priority. More Than Just A1C Control While GLP-1s are effective for lowering blood glucose, the added clinical benefits are just as important: Weight loss : Many patients experience a reduction of 10 percent or more in total body weight. Cardiovascular protection : Liraglutide, dulaglutide, and semaglutide have demonstrated reductions in major adverse cardiovascular events. Renal protection : These agents may slow the progression of chronic kidney disease. GLP-1s are also being studied for a wide range of potential uses, including nonalcoholic steatohepatitis (NASH), obstructive sleep apnea, heart failure with preserved ejection fraction, and even Alzheimers disease. What APRNs Should Know Before Starting GI side effects, particularly nausea and vomiting, are the most common patient complaints
GLP-1 is a natural incretin hormone produced by the intestines in response to food intake
[1] By increasing GH secretion, sermorelin can raise insulin-like growth factor 1 (IGF-1) levels in the body
Physical fatigue up to 1225% of patients report fatigue during treatment and higher doses increase the likelihood of feeling even more tired and exhausted
